ESMO 2023 – Revolution sets the bar in pan-KRAS inhibition
But efficacy in NSCLC has slipped since the abstract, and a high rate of rash raises eyebrows.
But efficacy in NSCLC has slipped since the abstract, and a high rate of rash raises eyebrows.
